{"id":70058,"date":"2025-10-03T00:42:26","date_gmt":"2025-10-03T03:42:26","guid":{"rendered":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/"},"modified":"2025-10-03T00:42:26","modified_gmt":"2025-10-03T03:42:26","slug":"opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence","status":"publish","type":"post","link":"https:\/\/ubirataonline.com.br\/en\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/","title":{"rendered":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence"},"content":{"rendered":"<p><\/p>\n<div>\n<figure data-testid=\"article-figure-image\" class=\"yf-8xybrv\">\n<div class=\"image-container yf-1gfnohs loader small\" style=\"--img-height: 36px;\">\n<div class=\"image-wrapper yf-1gfnohs small\" style=\"--img-width: 300px;\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Company Logo\" loading=\"eager\" height=\"36\" width=\"300\" class=\"yf-1gfnohs loader\"\/><\/div>\n<\/div><figcaption class=\"yf-8xybrv\"><!-- HTML_TAG_START -->Company Logo<!-- HTML_TAG_END -->  <\/figcaption><\/figure>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><em>The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie in decentralized trials, AI, personalized medicine, and expanding global presence, particularly in Asia-Pacific and Latin America, supported by technological advances.<\/em><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Dermatology CRO Market<!-- HTML_TAG_END --><\/p>\n<figure data-testid=\"article-figure-image\" class=\"yf-8xybrv\">\n<div class=\"image-container yf-1gfnohs loader\" style=\"--max-height: 400px;\">\n<div class=\"image-wrapper yf-1gfnohs\" style=\"--aspect-ratio: 600 \/ 400; --img-max-width: 600px;\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Dermatology CRO Market\" loading=\"lazy\" height=\"400\" width=\"600\" class=\"yf-1gfnohs loader\"\/><\/div>\n<\/div><figcaption class=\"yf-8xybrv\"><!-- HTML_TAG_START -->Dermatology CRO Market<!-- HTML_TAG_END -->  <\/figcaption><\/figure>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) &#8212; The <a href=\"https:\/\/www.researchandmarkets.com\/reports\/5457617\/dermatology-cro-market-size-share-and-trends?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2fmql7&amp;utm_campaign=2095836+-+Dermatology+CRO+Market+Trends+Analysis+Report+2025-2033%3a+Opportunities+Lie+in+Decentralized+Trials%2c+AI%2c+Personalized+Medicine%2c+and+Expanding+Presence&amp;utm_exec=chdomspi\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:&quot;Dermatology CRO Market Size, Share &amp; Trends Analysis Report by Type (Drug Discovery, Preclinical, Clinical), by Service (Clinical Monitoring, Project Management\/Clinical Supply Management, Data Management), by Region, and Segment Forecasts, 2025-2033&quot;;elm:context_link;itc:0;sec:content-canvas\" class=\"link\">&#8220;Dermatology CRO Market Size, Share &amp; Trends Analysis Report by Type (Drug Discovery, Preclinical, Clinical), by Service (Clinical Monitoring, Project Management\/Clinical Supply Management, Data Management), by Region, and Segment Forecasts, 2025-2033&#8221;<\/a> report has been added to <strong> ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p>The global dermatology CRO market size was estimated at USD 5.42 billion in 2024 and is projected to reach USD 9.09 billion by 2033, growing at a CAGR of 5.80% from 2025 to 2033. The dermatology contract research organization (CRO) market is experiencing robust growth, primarily driven by the rising prevalence of chronic skin conditions such as psoriasis, eczema, acne, and skin cancers across the globe. <\/p>\n<figure data-testid=\"article-figure-image\" class=\"yf-8xybrv\">\n<div class=\"image-container yf-1gfnohs loader\" style=\"--max-height: 400px;\">\n<div class=\"image-wrapper yf-1gfnohs\" style=\"--aspect-ratio: 600 \/ 400; --img-max-width: 600px;\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"\" loading=\"lazy\" height=\"400\" width=\"600\" class=\"yf-1gfnohs loader\"\/><\/div>\n<\/div>\n<\/figure>\n<p>Besides, growing interest of dermatological companies and increasing awareness of dermatological health, coupled with the expansion of the biopharmaceutical pipeline for innovative topical and systemic therapies is further driving the demand for specialized clinical research services. In addition, factors such as growing investments in dermatology R&amp;D, the rising adoption of personalized medicine, and enhanced patient participation facilitated by digital tools are expected to support the market growth.<\/p>\n<p>Moreover, the emerging trends such as decentralized clinical trials, tele dermatology, and AI-powered skin imaging are reshaping the dermatology clinical trial landscape, improving patient access and data accuracy. The increased use of wearable skin sensors and advanced imaging technologies is further enhancing real-time monitoring and endpoint assessment. Overall, the market scenario is favorable due to rising government initiatives supporting dermatology research, expanding applications in cosmetic dermatology, and increased clinical trial activity in emerging regions like Asia-Pacific and Latin America.<\/p>\n<p>Furthermore, the CROs are taking strategic initiatives such as expanding their geographic presence, forming partnerships with technology providers, and investing in integrated digital platforms to offer comprehensive dermatology trial solutions. In addition, technology advancements, including AI and machine learning for lesion analysis, decentralized trial platforms, and the integration of real-world data, enable CROs to enhance trial efficiency, patient engagement, and data quality, strengthening their competitive position in this dynamic market.<!-- HTML_TAG_END --><\/p>\n<\/p><\/div>\n<div style=\"display: none\" data-testid=\"read-more\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Why should you buy this report?<\/strong><!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Competitive Landscape: Explore the market presence of key players.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Future Trends: Discover the pivotal trends and drivers shaping the future of the market.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Key Attributes:<\/strong> <\/p>\n<div class=\"table-container yf-t4vsm6\">\n<table class=\"article-table yf-t4vsm6\">\n<tbody>\n<tr>\n<td data-testid=\"cell-0-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Report Attribute<\/strong><!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-0-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Details<\/strong><!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-1-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->No. of Pages<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-1-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->120<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-2-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Forecast Period<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-2-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->2024 &#8211; 2033<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-3-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Estimated Market Value (USD) in 2024<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-3-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->$5.42 Billion<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-4-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Forecasted Market Value (USD) by 2033<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-4-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->$9.09 Billion<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-5-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Compound Annual Growth Rate<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-5-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->5.8%<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-testid=\"cell-6-0\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Regions Covered<!-- HTML_TAG_END --><\/p>\n<\/td>\n<td data-testid=\"cell-6-1\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Global<!-- HTML_TAG_END --><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong><br \/>Market Dynamics<\/strong><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Market Driver Analysis<!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Rising Prevalence of Chronic and Complex Skin Disorders<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Increasing Adoption of Advanced Technologies<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Growing Demand for Aesthetic Dermatology and Cosmeceuticals<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Increasing Outsourcing of R&amp;D Activities<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Favorable Environment for Clinical Trials in Developing Countries<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Market Restraint Analysis<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Market Analysis Tools<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Companies Featured<\/strong><!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->IQVIA Inc.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Labcorp Drug Development<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Thermo Fisher Scientific Inc. (PPD)<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Parexel International Corp.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Parexel International Corp.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Charles River Laboratories<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->ICON, Plc<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Syneos Health<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Pharmaron<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Aragen Life Sciences Ltd.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Wuxi AppTec<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Medpace<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->CTI Clinical Trial &amp; Consulting<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Bioskin<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Proinnovera GmbH<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Biorasi, LLC<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Global Dermatology CRO Market Report Segmentation<\/strong><\/p>\n<p><strong>Type Outlook (Revenue, USD Million, 2021-2033)<\/strong><!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Drug Discovery<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Target Validation<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Lead Identification<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Lead optimization<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Preclinical<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Clinical<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Phase I<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Phase II<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Phase III<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Phase IV<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Service Outlook (Revenue, USD Million, 2021-2033)<\/strong><!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Project Management\/Clinical Supply Management<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Data Management<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Regulatory\/Medical Affairs<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Medical Writing<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Clinical Monitoring<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Quality Management\/ Assurance<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Bio-statistics<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Investigator Payments<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Laboratory<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Patient and Site Recruitment<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Technology<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Others<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Regional Outlook (Revenue, USD Million, 2021-2033)<\/strong><!-- HTML_TAG_END --><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->North America<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->U.S.<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Canada<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Mexico<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Europe<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->UK<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Germany<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->France<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Italy<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Spain<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Sweden<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Denmark<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Norway<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Asia-Pacific<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Japan<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->China<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->India<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Thailand<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->South Korea<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Australia<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Latin America<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Brazil<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Argentina<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Middle East &amp; Africa<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->South Africa<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Saudi Arabia<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Argentina<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->UAE<!-- HTML_TAG_END --><\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->Kuwait<!-- HTML_TAG_END --><\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->For more information about this report visit <a href=\"https:\/\/www.researchandmarkets.com\/reports\/5457617\/dermatology-cro-market-size-share-and-trends?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2fmql7&amp;utm_campaign=2095836+-+Dermatology+CRO+Market+Trends+Analysis+Report+2025-2033%3a+Opportunities+Lie+in+Decentralized+Trials%2c+AI%2c+Personalized+Medicine%2c+and+Expanding+Presence&amp;utm_exec=chdomspi\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:https:\/\/www.researchandmarkets.com\/r\/fewlri;elm:context_link;itc:0;sec:content-canvas\" class=\"link\">https:\/\/www.researchandmarkets.com\/r\/fewlri<\/a><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>About ResearchAndMarkets.com<\/strong><br \/>ResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START --><strong>Attachment<\/strong><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1090901\"><!-- HTML_TAG_START -->CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S.\/ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900<!-- HTML_TAG_END --><\/p>\n<\/p><\/div>\n<p><a href=\"https:\/\/uk.finance.yahoo.com\/news\/dermatology-cro-market-trends-analysis-133800334.html\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie in decentralized trials, AI, personalized medicine, and expanding global presence, particularly in Asia-Pacific and Latin America, supported by technological advances. Dermatology CRO Market Dermatology CRO Market Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) &#8212; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":70059,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAow2JLhCw:productID":"","_gspb_post_css":"","maa_idioma":"","maa_pais":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-70058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brasil"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!<\/title>\n<meta name=\"description\" content=\"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ubirataonline.com.br\/en\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence\" \/>\n<meta property=\"og:description\" content=\"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ubirataonline.com.br\/en\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/\" \/>\n<meta property=\"og:site_name\" content=\"Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/portalubirataonline\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-03T03:42:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/logo2026.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1531\" \/>\n\t<meta property=\"og:image:height\" content=\"418\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ubirataonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ubirataonline\" \/>\n<meta name=\"twitter:site\" content=\"@ubirataonline\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ubirataonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/\"},\"author\":{\"name\":\"ubirataonline\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#\\\/schema\\\/person\\\/372f87bbd3fdd79b8556b84c98d0bc1c\"},\"headline\":\"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence\",\"datePublished\":\"2025-10-03T03:42:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/\"},\"wordCount\":766,\"publisher\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/ab07afac2ee65efc2579a4ee44a5804b.png\",\"articleSection\":[\"Brasil\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/\",\"name\":\"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/ab07afac2ee65efc2579a4ee44a5804b.png\",\"datePublished\":\"2025-10-03T03:42:26+00:00\",\"description\":\"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/ab07afac2ee65efc2579a4ee44a5804b.png\",\"contentUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/ab07afac2ee65efc2579a4ee44a5804b.png\",\"width\":600,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ubirataonline.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#website\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/\",\"name\":\"Ubirat\u00e3 Online Not\u00edcias\",\"description\":\"Not\u00edcias de Ubirat\u00e3, regi\u00e3o, Brasil e mundo, com informa\u00e7\u00e3o atualizada e compromisso com o leitor.\",\"publisher\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\"},\"alternateName\":\"Ubirat\u00e3 Online\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ubirataonline.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\",\"name\":\"Ubirat\u00e3 Online Not\u00edcias\",\"alternateName\":\"Ubirat\u00e3 Online\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#local-main-organization-logo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/portalubirataonline\",\"https:\\\/\\\/x.com\\\/ubirataonline\",\"https:\\\/\\\/mastodon.social\\\/@ubirataonline\",\"https:\\\/\\\/www.facebook.com\\\/groups\\\/311144672285604\",\"https:\\\/\\\/www.facebook.com\\\/UBTAOnline\",\"https:\\\/\\\/www.instagram.com\\\/portalubirataonline\\\/\",\"https:\\\/\\\/twitter.com\\\/ubirataonline\"],\"description\":\"Somos um portal de not\u00edcias independente, criado em 5 de janeiro de 2009, com o objetivo de informar, conectar e valorizar a nossa comunidade de Ubirat\u00e3 e toda aregi\u00e3o. Com conte\u00fado atualizado, confi\u00e1vel e relevante, o Ubirat\u00e3 Online \u00e9 o seu espa\u00e7o para ficar por dentro dos principais acontecimentos locais, regionais, Brasil, Mundo e de interesse geral. Nosso compromisso \u00e9 com a verdade, a transpar\u00eancia e o respeito ao leitor.\",\"legalName\":\"UBIRATA ONLINE NOT\u00cdCIAS\",\"foundingDate\":\"2009-01-05\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"1\",\"maxValue\":\"10\"},\"publishingPrinciples\":\"https:\\\/\\\/ubirataonline.com.br\\\/faq\\\/\",\"address\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#local-main-place-address\"},\"geo\":{\"@type\":\"GeoCoordinates\",\"latitude\":\"-24.5361401\",\"longitude\":\"-52.9921776\"},\"telephone\":[\"+5544998308235\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"email\":\"contato@ubirataonline.com.br\"},\"openingHoursSpecification\":{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\",\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"23:59\"},\"email\":\"contato@ubirataonline.com.br\",\"vatID\":\"47.621.418\\\/0001-80\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#\\\/schema\\\/person\\\/372f87bbd3fdd79b8556b84c98d0bc1c\",\"name\":\"ubirataonline\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/en\\\/author\\\/ubirataonline\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#local-main-place-address\",\"streetAddress\":\"Rua dos Coqueiros, 104 - Bairro Boa Vista, Rua dos Coqueiros, 104 Bairro Boa Vista\",\"addressLocality\":\"UBIRATA\",\"postalCode\":\"85440-000\",\"addressRegion\":\"PR\",\"addressCountry\":\"BR\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logoubirataonline-1.webp\",\"contentUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logoubirataonline-1.webp\",\"width\":500,\"height\":500,\"caption\":\"Ubirat\u00e3 Online Not\u00edcias\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"UBIRATA\" \/>\n<meta name=\"geo.position\" content=\"-24.5361401;-52.9921776\" \/>\n<meta name=\"geo.region\" content=\"Brazil\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","description":"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ubirataonline.com.br\/en\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/","og_locale":"en_US","og_type":"article","og_title":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence","og_description":"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie","og_url":"https:\/\/ubirataonline.com.br\/en\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/","og_site_name":"Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","article_publisher":"https:\/\/www.facebook.com\/portalubirataonline","article_published_time":"2025-10-03T03:42:26+00:00","og_image":[{"width":1531,"height":418,"url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/logo2026.webp","type":"image\/webp"}],"author":"ubirataonline","twitter_card":"summary_large_image","twitter_creator":"@ubirataonline","twitter_site":"@ubirataonline","twitter_misc":{"Written by":"ubirataonline","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#article","isPartOf":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/"},"author":{"name":"ubirataonline","@id":"https:\/\/ubirataonline.com.br\/#\/schema\/person\/372f87bbd3fdd79b8556b84c98d0bc1c"},"headline":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence","datePublished":"2025-10-03T03:42:26+00:00","mainEntityOfPage":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/"},"wordCount":766,"publisher":{"@id":"https:\/\/ubirataonline.com.br\/#organization"},"image":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#primaryimage"},"thumbnailUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2025\/10\/ab07afac2ee65efc2579a4ee44a5804b.png","articleSection":["Brasil"],"inLanguage":"en-US","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/ubirataonline.com.br\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/","url":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/","name":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","isPartOf":{"@id":"https:\/\/ubirataonline.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#primaryimage"},"image":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#primaryimage"},"thumbnailUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2025\/10\/ab07afac2ee65efc2579a4ee44a5804b.png","datePublished":"2025-10-03T03:42:26+00:00","description":"Company Logo The dermatology CRO market is growing due to rising skin conditions, increased R&amp;D investments, and digital tool use. Opportunities lie","breadcrumb":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#primaryimage","url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2025\/10\/ab07afac2ee65efc2579a4ee44a5804b.png","contentUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2025\/10\/ab07afac2ee65efc2579a4ee44a5804b.png","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ubirataonline.com.br\/"},{"@type":"ListItem","position":2,"name":"Opportunities Lie in Decentralized Trials, AI, Personalized Medicine, and Expanding Presence"}]},{"@type":"WebSite","@id":"https:\/\/ubirataonline.com.br\/#website","url":"https:\/\/ubirataonline.com.br\/","name":"Ubirat\u00e3 Online Not\u00edcias","description":"Not\u00edcias de Ubirat\u00e3, regi\u00e3o, Brasil e mundo, com informa\u00e7\u00e3o atualizada e compromisso com o leitor.","publisher":{"@id":"https:\/\/ubirataonline.com.br\/#organization"},"alternateName":"Ubirat\u00e3 Online","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ubirataonline.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/ubirataonline.com.br\/#organization","name":"Ubirat\u00e3 Online Not\u00edcias","alternateName":"Ubirat\u00e3 Online","url":"https:\/\/ubirataonline.com.br\/","logo":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#local-main-organization-logo"},"image":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#local-main-organization-logo"},"sameAs":["https:\/\/www.facebook.com\/portalubirataonline","https:\/\/x.com\/ubirataonline","https:\/\/mastodon.social\/@ubirataonline","https:\/\/www.facebook.com\/groups\/311144672285604","https:\/\/www.facebook.com\/UBTAOnline","https:\/\/www.instagram.com\/portalubirataonline\/","https:\/\/twitter.com\/ubirataonline"],"description":"Somos um portal de not\u00edcias independente, criado em 5 de janeiro de 2009, com o objetivo de informar, conectar e valorizar a nossa comunidade de Ubirat\u00e3 e toda aregi\u00e3o. Com conte\u00fado atualizado, confi\u00e1vel e relevante, o Ubirat\u00e3 Online \u00e9 o seu espa\u00e7o para ficar por dentro dos principais acontecimentos locais, regionais, Brasil, Mundo e de interesse geral. Nosso compromisso \u00e9 com a verdade, a transpar\u00eancia e o respeito ao leitor.","legalName":"UBIRATA ONLINE NOT\u00cdCIAS","foundingDate":"2009-01-05","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"1","maxValue":"10"},"publishingPrinciples":"https:\/\/ubirataonline.com.br\/faq\/","address":{"@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#local-main-place-address"},"geo":{"@type":"GeoCoordinates","latitude":"-24.5361401","longitude":"-52.9921776"},"telephone":["+5544998308235"],"contactPoint":{"@type":"ContactPoint","email":"contato@ubirataonline.com.br"},"openingHoursSpecification":{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday","Saturday","Sunday"],"opens":"00:00","closes":"23:59"},"email":"contato@ubirataonline.com.br","vatID":"47.621.418\/0001-80"},{"@type":"Person","@id":"https:\/\/ubirataonline.com.br\/#\/schema\/person\/372f87bbd3fdd79b8556b84c98d0bc1c","name":"ubirataonline","url":"https:\/\/ubirataonline.com.br\/en\/author\/ubirataonline\/"},{"@type":"PostalAddress","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#local-main-place-address","streetAddress":"Rua dos Coqueiros, 104 - Bairro Boa Vista, Rua dos Coqueiros, 104 Bairro Boa Vista","addressLocality":"UBIRATA","postalCode":"85440-000","addressRegion":"PR","addressCountry":"BR"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubirataonline.com.br\/opportunities-lie-in-decentralized-trials-ai-personalized-medicine-and-expanding-presence\/#local-main-organization-logo","url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/06\/logoubirataonline-1.webp","contentUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/06\/logoubirataonline-1.webp","width":500,"height":500,"caption":"Ubirat\u00e3 Online Not\u00edcias"}]},"geo.placename":"UBIRATA","geo.position":{"lat":"-24.5361401","long":"-52.9921776"},"geo.region":"Brazil"},"_links":{"self":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts\/70058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/comments?post=70058"}],"version-history":[{"count":0,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts\/70058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/media\/70059"}],"wp:attachment":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/media?parent=70058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/categories?post=70058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/tags?post=70058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}